¹⁸F-PSMA-1007 PET in Biochemical Recurrent Prostate Cancer: An Updated Meta-Analysis

Figure 3

Plots of individual studies and pooled detection rate of ¹⁸F-PSMA-1007 PET/CT or PET/MRI in biochemically recurrent prostate cancer on a per scan-based analysis. Meta-analysis was performed using a random-effects model. Pooled values were presented along with corresponding 95% confidence intervals (95% CI) values. The size of the squares indicates the weight of each study.